BR9911349A - Genes para a biossìntese de epotilonas - Google Patents

Genes para a biossìntese de epotilonas

Info

Publication number
BR9911349A
BR9911349A BR9911349-0A BR9911349A BR9911349A BR 9911349 A BR9911349 A BR 9911349A BR 9911349 A BR9911349 A BR 9911349A BR 9911349 A BR9911349 A BR 9911349A
Authority
BR
Brazil
Prior art keywords
genes
epothilone
biosynthesis
epothilone biosynthesis
biosysynthesis
Prior art date
Application number
BR9911349-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Schupp
James Madison Ligon
Istvan Molnar
Ross Zirkle
Joern Goerlach
Devon Cyr
Original Assignee
Novartis Ag Novartis S A Novar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag Novartis S A Novar filed Critical Novartis Ag Novartis S A Novar
Publication of BR9911349A publication Critical patent/BR9911349A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
BR9911349-0A 1998-06-18 1999-06-16 Genes para a biossìntese de epotilonas BR9911349A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US10163198P 1998-09-24 1998-09-24
US11890699P 1999-02-05 1999-02-05
PCT/EP1999/004171 WO1999066028A2 (en) 1998-06-18 1999-06-16 Genes for the biosynthesis of epothilones

Publications (1)

Publication Number Publication Date
BR9911349A true BR9911349A (pt) 2001-03-13

Family

ID=27378840

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911349-0A BR9911349A (pt) 1998-06-18 1999-06-16 Genes para a biossìntese de epotilonas

Country Status (16)

Country Link
EP (1) EP1088078A2 (hu)
JP (3) JP2002518004A (hu)
KR (1) KR100511233B1 (hu)
CN (1) CN100374565C (hu)
AU (1) AU753567B2 (hu)
BR (1) BR9911349A (hu)
CA (1) CA2329774A1 (hu)
HU (1) HUP0102186A3 (hu)
ID (1) ID29128A (hu)
IL (3) IL139735A0 (hu)
NO (2) NO20006195L (hu)
NZ (1) NZ508326A (hu)
PL (1) PL200157B1 (hu)
SK (1) SK19242000A3 (hu)
TR (1) TR200003759T2 (hu)
WO (1) WO1999066028A2 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
KR100716272B1 (ko) * 1998-11-20 2007-05-09 코산 바이오사이언시즈, 인코포레이티드 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
AU2001245263A1 (en) * 2000-01-21 2001-07-31 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
ATE444368T1 (de) * 2000-04-28 2009-10-15 Kosan Biosciences Inc Kristallines epothilon d
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
US6989450B2 (en) 2000-10-13 2006-01-24 The University Of Mississippi Synthesis of epothilones and related analogs
ES2337134T3 (es) 2002-03-12 2010-04-21 Bristol-Myers Squibb Company Derivados de c3-ciano-epotilona.
AU2006211216B2 (en) * 2005-01-31 2011-02-03 Merck Sharp & Dohme Llc Purification process for plasmid DNA
EP2668284B1 (en) 2011-01-28 2014-10-15 Amyris, Inc. Gel-encapsulated microcolony screening
CN103518136A (zh) 2011-05-13 2014-01-15 阿迈瑞斯公司 用于检测水不混溶性化合物的微生物生成的方法和组合物
WO2014025941A1 (en) 2012-08-07 2014-02-13 Jiang Hanxiao Methods for stabilizing production of acetyl-coenzyme a derived compounds
MX364748B (es) 2013-03-15 2019-05-06 Amyris Inc Uso de fosfoquetolasa y fosfotransacetilasa para la produccion de compuestos derivados de acetil-coenzima a.
BR112016002526B1 (pt) 2013-08-07 2021-11-23 Total Marketing Services Método para produção de um composto heterólogo não catabólico, e, composição de fermentação
CN108474009B (zh) 2015-06-25 2022-10-04 阿迈瑞斯公司 麦芽糖依赖性降解决定子、麦芽糖响应型启动子、稳定化构建体及其在生成非分解代谢化合物中的用途
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100344627C (zh) * 1996-11-18 2007-10-24 生物技术研究有限公司(Gbf) 埃坡霉素c、其制备方法以及作为细胞抑制剂和植物保护剂的应用

Also Published As

Publication number Publication date
NZ508326A (en) 2003-10-31
CN100374565C (zh) 2008-03-12
NO20006195L (no) 2001-02-16
CA2329774A1 (en) 1999-12-23
PL200157B1 (pl) 2008-12-31
EP1088078A2 (en) 2001-04-04
IL139735A0 (en) 2002-02-10
KR100511233B1 (ko) 2005-08-31
CN1305530A (zh) 2001-07-25
HUP0102186A2 (hu) 2001-10-28
IL190391A0 (en) 2008-11-03
AU4611699A (en) 2000-01-05
KR20010052962A (ko) 2001-06-25
NO20091055L (no) 2001-02-16
WO1999066028A2 (en) 1999-12-23
PL345579A1 (en) 2001-12-17
IL139735A (en) 2009-06-15
AU753567B2 (en) 2002-10-24
JP2002518004A (ja) 2002-06-25
HUP0102186A3 (en) 2005-10-28
NO20006195D0 (no) 2000-12-06
ID29128A (id) 2001-08-02
WO1999066028A3 (en) 2000-06-29
TR200003759T2 (tr) 2001-06-21
JP2006061166A (ja) 2006-03-09
JP2008092958A (ja) 2008-04-24
SK19242000A3 (sk) 2001-07-10

Similar Documents

Publication Publication Date Title
BR9911349A (pt) Genes para a biossìntese de epotilonas
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
ATE532860T1 (de) B7-ähnliche moleküle und deren anwendungen
WO2001079443A3 (en) Albumin fusion proteins
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
BR9910311A (pt) Moléculas de ácido nucléico codificando enzimas do trigo, que participam da sìntese do amido
WO2003060071A3 (en) Albumin fusion proteins
DE69942861D1 (de) Ldcam genannte moleküle
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
ATE415480T1 (de) B7l-1 moleküle
WO2002014485A3 (en) Kallikrein gene
BR0011033A (pt) Métodos de purificação de dna e dna purificado
BR9908215A (pt) Derivados de ácidos hidroxâmico e carboxìlico
BR0206852A (pt) Conjugados de polìmero de neublastina e métodos para uso dos mesmos
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
NO991161D0 (no) TNF-<beta>-lignende protein for behandling av prostatakreft, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
BR9911785A (pt) Combinações de farnesil transferase de proteìna e inibidores de redutase de hmg coa e seu uso para tratar câncer
BR9806183A (pt) Quinases de proteìna e usos das mesmas
ATE340257T1 (de) Histonedeacetylase 9
HUP9801681A2 (hu) Mutáns proteinek

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10, 24, 25 E 37 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]